Find clinical trials for Ovarian Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near New York, NY, USA:
Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The study is pl...
Phase 3
New York, New York, United States and 10 other locations
in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...
Phase 3
New York, New York, United States and 207 other locations
The goal of this clinical trial is to learn if the experimental antibody COM701 delays the progression of ovarian cancer in partici ...
Phase 1, Phase 2
New York, New York, United States and 27 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
New York, New York, United States and 213 other locations
effectiveness of TUB-040 when given in combination with standard ovarian cancer treatments in participants with high-grade epitheli ...
Phase 1, Phase 2
New York, New York, United States and 7 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Mineola, New York, United States and 126 other locations
bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...
Phase 3
Stony Brook, New York, United States and 32 other locations
be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the saf...
Phase 1, Phase 2
New York, New York, United States and 8 other locations
Ovarian cancer is a lethal disease with an estimated 310,000 new cases and 200,000 deaths experienced worldwide in 2020. The purpos ...
Phase 2
New York, New York, United States and 83 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
New York, New York, United States and 46 other locations
Clinical trials
Research sites
Resources
Legal